DSM-Firmenich AG 2015 IR
The report outlines Royal DSM's performance in 2015, marking the final year of its 'DSM in motion: driving focused growth' strategy. The company achieved net sales of ‐7.7 billion and an EBITDA of ‐1,075 million, driven by strong volumes in the Nutrition cluster. Key strategic milestones included establishing the ChemicalInvest partnership with CVC Capital Partners to simplify its portfolio. DSM also launched its 'Strategy 2018: Driving Profitable Growth' and stepped up its sustainability targets, aiming for a 45% greenhouse gas efficiency improvement by 2025.
Company: DSM-Firmenich AG
Sector: Manufacturing
Country: Switzerland
Year: 2015
Type: IR
Pages: 214
DSM-Firmenich AG
The report outlines Royal DSM's performance in 2015, marking the final year of its 'DSM in motion: driving focused growth' strategy. The company achieved net sales of ‐7.7 billion and an EBITDA of ‐1,075 million, driven by strong volumes in the Nutrition cluster. Key strategic milestones included establishing the ChemicalInvest partnership with CVC Capital Partners to simplify its portfolio. DSM also launched its 'Strategy 2018: Driving Profitable Growth' and stepped up its sustainability targets, aiming for a 45% greenhouse gas efficiency improvement by 2025.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Employees